Prostaglandin E2 production in astrocytes: Regulation by cytokines, extracellular ATP, and oxidative agents

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 69, Issue 6, 2003, Pages 437-448

  Xu, J ^a   Chalimoniuk, M ^a,b   Shu, Y ^c   Simonyi, A ^a,c   Sun, A Y ^c   Gonzalez, F A ^d   Weisman, G A ^a,c   Wood, W G ^e   Sun, G Y ^a,c  

^a University of Missouri   (United States)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c UNIVERSITY OF MISSOURI   (United States)

^d UNIVERSITY OF PUERTO RICO RIO PIEDRAS   (Puerto Rico)

^e UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Arachidonic acid; ATP; Cyclooxygenases; Cytokines; H 2O2; Nitric oxide; Phorbol myristate acetate; Phospholipases A2; Prostaglandin E2

Indexed keywords

ADENOSINE TRIPHOSPHATE; ARACHIDONIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; MENADIONE; PHORBOL ESTER; PHOSPHOLIPASE A2; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA; NITRIC OXIDE; OXIDIZING AGENT; PHOSPHOLIPASE A; PROSTAGLANDIN SYNTHASE; PURINE P2 RECEPTOR;

ANIMAL CELL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; CYTOSOL; ENZYME PHOSPHORYLATION; EXTRACELLULAR SPACE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; DRUG EFFECT; DRUG POTENTIATION; IMMUNOCHEMISTRY; METABOLISM; MOUSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ARACHIDONIC ACID; ASTROCYTES; CYTOKINES; DINOPROSTONE; FEMALE; HYDROGEN PEROXIDE; IMMUNOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; OXIDANTS; PHOSPHOLIPASES A; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P2; RNA, MESSENGER; VITAMIN K 3;

EID: 0345304316     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2003.08.016     Document Type: Article

References (69)

1. 2 and its role in brain tissue, J. Neurochem. 69 (1997) 889-901.
2. 2s in cell injury and death, J. Pharmacol. Exp. Ther. 294 (3) (2000) 793-799.
3. 2, Clin. Rev. Immunol. 17 (1997) 225-283.
4. 2, J. Biochem. 131 (2002) 285-292.
5. 2 are expressed in rat brain, Neurosci. Lett. 258 (1998) 139-142.
6. E.N. Benveniste, Inflammatory cytokines within the central nervous system: source, function, and mechanism of action, Am. J. Physiol. 263 (1992) C1-C16.
7. 2 in immortalized astrocytes (DITNC): response to genistein and pyrrolidine dithiocarbamate, J. Interferon Cytokine Res. 19 (1999) 121-127.
8. 2 production from primary mouse astrocytes independent of nitric oxide formation, J. Neuroimmunol. 94 (1999) 134-143.
9. 2 in rat cultured astrocytes, J. Biol. Chem. 266 (1991) 9956-9960.
10. 2 isoforms in rat striatal astrocytes, Neurosci. Lett. 247 (2-3) (1998) 83-86.
11. 2 mRNA expression and release in an immortalized astrocyte cell line (DITNC) by LPS, TNFα, and IL-1β: interactive effects, Mol. Chem. Neuropath. 25 (1995) 1-17.
12. 2 phosphorylation and arachidonic acid release in primary murine astrocytes, J. Neurochem. 83 (2002) 259-270.
13. 2, Free Radical Biol. Med. 34 (2003) 1531-1543.
14. K.T. Akama, L.J. Van Eldik, β-amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β and tumor necrosis factor-α (TNFα )-dependent, and involves a TNFα receptor-associated factor and NFκB-inducing kinase-dependent signaling mechanism, J. Biol. Chem. 275 (2000) 7918-7924.
15. D.T. Stephenson, CA. Lemere, D.J. Selkoe, J.A. Clemens, Cytosolic phospholipase A2 (cPLA2) immunoreactivity is elevated in Alzheimer's disease brain, Neurobiol. Dis. 3 (1996) 51-63.
16. 2 after transient global forebrain ischemia in the rat, Stroke 27 (1996) 527-535.
17. J.R. Vane, Aspirin and other anti-inflammatory drugs, Thorax 55 (2000) 53-59.
18. N.V. Chandrasekharan, H. Dai, L.T. Roos, N.K. Evanson, J. Tomsik, T.S. Elton, D.L. Simmons, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression, Proc. Natl. Acad. Sci. USA 99 (2002) 13926-13931.
19. W.D. Hirst, K.A. Young, R. Newton, V.C. Allport, D.R. Marriott, G.P. Wilkin, Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system, Mol. Cell. Neurosci. 13 (1999) 57-68.
20. S. Kyrkanides, A.H. Moore, J.A. Olschowka, J.C. Daeschner, J.P. Williams, J.T. Hansen, M.K. O'Banion, Cyclooxygenase-2 modulates brain inflammation-related gene expression in central nervous system radiation injury, Mol. Brain Res. 104 (2002) 159-169.
21. A.V. Yermakova, M.K. O'Banion, Downregulation of neuronal cyclooxygenase-2 expression in end stage Alzheimer's disease, Neurobiol. Aging 22 (2001) 823-836.
22. M.K. O'Banion, J.C. Miller, J.W. Chang, M.D. Kaplan, P.D. Coleman, Interleukin-1β induces prostaglandin G/H synthase-2 (cyclooxygenase-2) in primary murine astrocyte cultures, J. Neurochem. 66 (1996) 2532-2540.
23. E.T. Dayton, E.O. Major, Recombinant human interleukin-1β induces production of prostaglandins in primary human fetal astrocytes and immortalized human fetal astrocyte cultures, J. Neuroimmunol. 71 (1996) 11-18.
24. J. Luo, J.A. Lang, M.W. Miller, Transforming growth factor β1 regulates the expression of cyclooxygenase in cultured cortical astrocytes and neurons, J. Neurochem. 71 (1998) 526-534.
25. G. Pistritto, C. Mancuso, G. Tringali, M. Perretti, P. Preziosi, P. Navarra, The relative contribution of constitutive and inducible cyclooxygenase activity to lipopolysaccharide-induced prostaglandin production by primary cultures of rat hypothalamic astrocytes, Neurosci. Lett. 246 (1998) 45-48.
26. G. Pistritto, O. Franzese, G. Pozzoli, C. Mancuso, G. Tringali, P. Preziosi, P. Navarra, Bacterial lipopolysaccharide increases prostaglandin production by rat astrocytes via inducible cyclooxygenase: evidence for the involvement of nuclear factor kappaB, Biochem. Biophys. Res. Comm. 263 (1999) 570-574.
27. E. Molina-Holgado, S. Ortiz, F. Molina-Holgado, C. Guaza, Induction of COX-2 and PGE2 biosynthesis by IL-1b is mediated by PKC and mitogen activated protein kinases in murine astrocytes, Brit. J. Pharmacol. 131 (2000) 152-159.
28. R. Brambilla, P. Schiller, G. D'Ippolito, J.T. Neary, G. Burnstock, F. Cattabeni, M.P. Abbracchio, Identification of a novel P2 receptor associated with cyclooxygenase-2 upregulation and reactive astrogliosis, Drug Dev. Res. 53 (2-3) (2001) 148-157.
29. 2, cyclooxygenases, and terminal prostanoid synthases in different phases of prostanoid biosynthesis in rat peritoneal macrophages, J. Immunol. 160 (1998) 2974-2982.
30. 2 in activated mast cells, J. Biol. Chem. 272 (1997) 3231-3237.
31. 2 generation in rat 3Y1 fibroblasts, J. Biol. Chem. 273 (1998) 1733-1740.
32. 2-dependent induction of cyclooxygenase-2 in macrophages, J. Biol. Chem. 274 (1999) 25967-25970.
33. 2 modulates tumor necrosis factor-α-and interleukin-1β-induced NF-κB activation, J. Biol. Chem. 22 (2001) 30527-30536.
34. K.D. McCarthy, J. de Vellis, Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue, J. Cell Biol. 85 (1980) 890-902.
35. 2 in immortalized astrocytes (DITNC) revealed new properties of the calcium ionophore, A23187, Neurochem. Res. 24 (1999) 1285-1291.
36. S. Nogawa, F. Zhang, M.E. Ross, C. Iadecola, Cyclooxygenase-2 gene expression in neurons contributes to ischemic brain damage, J. Neurosci. 17 (1997) 2746-2755.
37. 2 enzymes present in P388D1 macrophages, J. Biol. Chem. 271 (1996) 6758-6765.
38. 2 gene in inbred mouse strains, J. Biol. Chem. 270 (1995) 22378-22385.
39. 2, J. Biol. Chem. 268 (1993) 20713-20716.
40. 2, on human neutrophil function, Biochem. Pharmacol. 47 (1994) 1661-1667.
41. J.L. Masferrer, B.S. Zweifel, P.T. Manning, S.D. Hauser, K.M. Leahy, W.G. Smith, P.C. Isakson, K. Seibert, Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic, Proc. Natl. Acad. Sci. USA 91 (1994) 3228-3232.
42. 2U purinoceptors: positively charged amino acids in transmembrane helices 6 and 7 affect agonist potency and specificity, J. Biol. Chem. 270 (1995) 4185-4188.
43. 7 nucleotide receptors that mediate neuroinflammatory responses in astrocytes and microglial, cells, Biomed. Res. 14 (2003) 47-61.
44. 2 in cultured rat astrocytes, J. Biol. Chem. 275 (2000) 10876-10886.
45. 2 by antisense and effects on endotoxin-induced prostaglandin biosynthesis, J. Biol. Chem. 269 (1994) 25999-26005.
46. 2, J. Biol. Chem. 272 (1997) 19891-19897.
47. 2s, J. Biol. Chem. 274 (1999) 12263-12268.
48. 2 in rat renal mesangial cells, Br. J. Pharmacol. 121 (1997) 787-793.
49. 2 gene in vascular smooth muscle cells by a nuclear factor kappaB and peroxisome proliferator-activated receptor-mediated process, J. Biol. Chem. 274 (1999) 23085-23093.
50. J. Spink, J. Cohen, T.J. Evans, The cytokine responsive vascular smooth muscle cell enhancer of inducible nitric oxide synthase. Activation by nuclear factor-kappa B, J. Biol. Chem. 270 (1995) 29541-29547.
51. J.A. Diehl, W. Tong, G.Y. Sun, M. Hannink, Tumor necrosis factor-α-dependent activation of a RelA homodimer in astrocytes, J. Biol. Chem. 270 (1995) 2703-2707.
52. 2 in the human astrocytoma cell line 1321N1, J. Biol. Chem. 273 (1998) 606-612.
53. 2 by human cultured astroglial cells, Brit. J. Pharmacol. 124 (1998) 742-746.
54. G. Pistritto, G. Ciabattoni, C. Mancuso, G. Tringali, P. Preziosi, P. Navarra, Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells, J. Endotoxin Res. 6 (2000) 307-311.
55. A. Barchowsky, R.S. Kent, A.R. Whorton, Recovery of porcine aortic endothelial cell prostaglandin synthesis following inhibition by sublethal concentrations of hydrogen peroxide, Biochim. Biophys. Acta 927 (1987) 372-381.
56. A. Barchowsky, K. Tabrizi, R.S. Kent, A.R. Whorton, Inhibition of prostaglandin synthesis after metabolism of menadione by cultured porcine endothelial cells, J. Clin. Invest. 83 (1989) 1153-1159.
57. S. Adler, R.A. Stahl, P.J. Baker, Y.P. Chen, P.M. Pritzl, W.G. Couser, Biphasic effect of oxygen radicals on prostaglandin production by rat mesangial cells, Am. J. Physiol. 252 (1987) F743-F749.
58. 2 synthesis after oxidant stress is dependent on cell glutathione content, Am. J. Physiol. 266 (1994) C1392-C1399.
59. P.H. Sporn, M. Peters-Golden, R.H. Simon, Hydrogen-peroxide-induced arachidonic acid metabolism in the rat alveolar macrophage, Am. Rev. Respir. Dis. 137 (1988) 49-56.
60. I. Schimke, A. Griesmacher, G. Weigel, H.G. Holzhutter, M.M. Muller, Effect of reactive oxygen species on eicosanoid metabolism in human endothelial cells, Prostaglandins 43 (1992) 281-292.
61. G.M. Vercellotti, S.P. Severson, P. Duane, C.F. Moldow, Hydrogen peroxide alters signal transduction in human endothelial cells, J. Lab. Clin. Med. 117 (1991) 15-24.
62. M. Kolko, M.A. Decoster, E.B. Rodriquez de Turco, N.G. Bazan, Synergy by secretory phospholipase A-2 and glutamate on inducing cell death and sustained arachidonic acid metabolic changes in primary cortical neuronal cultures, J. Biol. Chem. 271 (1996) 32711-32728.
63. 2 potentiates glutamate-induced rat striatal neuronal cell death in vivo, Neurosci. Lett. 274 (1999) 167-170.
64. 2 stimulates inducible nitric oxide synthase expression via ERK and NF-kappaB in macrophages, Eur. J. Immunol. 31 (2001) 2709-2717.
65. 2 induces delayed neuronal COX-2 expression compared with glutamate, J. Neurosci. Res. 69 (2) (2002) 169-177.
66. 2 expression and motility in activated primary human keratinocytes, J. Invest. Dermatol. 120 (2003) 86-95.
67. 2 modulate the release of arachidonic acid from neuronal membranes, J. Neurosci. Res. 68 (5) (2002) 558-567.
68. 2 potentiates glutamate-induced calcium increase and cell death in primary neuronal cultures, J. Neurosci. Res. 67 (2002) 634-645.
69. 2 stimulates amyloid precursor protein gene expression: inhibition by immunosuppressants, J. Neurosci. 19 (1999) 940-947.